Results

• All
• Video
• Audio
• Images

• Most recent

1–3 of 3 results for Ixoberogene Soroparvovec

• 

  Ixoberogene Soroparvovec (Ixo-vec) IVT Gene Therapy for Neovascular AMD: First-Time 26-Week Interim Analysis Results From the Phase 2 LUNA Study

  Charles C Wykoff, MD, PhD, FASRS

  Annual Meeting Talks

  2024

• 

  Ixoberogene Soroparvovec (Ixo-vec) IVT Gene Therapy for Neovascular AMD: Phase 2 LUNA Study Update

  Glenn C. Yiu, MD, PhD

  Updates from the Field

  2025

• 

  Ixoberogene Soroparvovec (Ixo-vec) IVT Gene Therapy for Neovascular AMD: First Time 26-Week Interim Analysis Results from the Phase 2 LUNA Study

  Charles C Wykoff, MD, PhD, FASRS

  Updates from the Field

  2024